e-Article
Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial
Document Type
Article
Author
Powell, M.A.; Bjørge, L.; Willmott, L.; Novák, Z.; Black, D.; Gilbert, L.; Sharma, S.; Valabrega, G.; Landrum, L.M.; Gropp-Meier, M.; Stuckey, A.; Boere, I.; Gold, M.A.; Segev, Y.; Gill, S.E.; Gennigens, C.; Sebastianelli, A.; Shahin, M.S.; Pothuri, B.; Monk, B.J.; Buscema, J.; Coleman, R.L.; Slomovitz, B.M.; Ring, K.L.; Herzog, T.J.; Marco Balas, M.; Grimshaw, M.; Stevens, S.; Lai, D.W.; McCourt, C.; Mirza, M.R.
Source
In Annals of Oncology
Subject
Language
ISSN
0923-7534